Morton C - Search Results

1

Developing new agents for the treatment of childhood cancer.

Kurmasheva R, Morton C, Houghton PJ. Kurmasheva R, et al. Among authors: morton c. Curr Opin Investig Drugs. 2005 Dec;6(12):1215-27. Curr Opin Investig Drugs. 2005. PMID: 16372407 Review.

2

Factors that influence the therapeutic activity of 5-fluorouracil [6RS]leucovorin combinations in colon adenocarcinoma xenografts.

Houghton JA, Williams LG, Loftin SK, Cheshire PJ, Morton CL, Houghton PJ, Dayan A, Jolivet J. Houghton JA, et al. Among authors: morton cl. Cancer Chemother Pharmacol. 1992;30(6):423-32. doi: 10.1007/BF00685592. Cancer Chemother Pharmacol. 1992. PMID: 1394798

3

Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy.

Danks MK, Morton CL, Krull EJ, Cheshire PJ, Richmond LB, Naeve CW, Pawlik CA, Houghton PJ, Potter PM. Danks MK, et al. Among authors: morton cl. Clin Cancer Res. 1999 Apr;5(4):917-24. Clin Cancer Res. 1999. PMID: 10213229

4

Efficacy and toxicity of a virus-directed enzyme prodrug therapy purging method: preclinical assessment and application to bone marrow samples from neuroblastoma patients.

Wagner LM, Guichard SM, Burger RA, Morton CL, Straign CM, Ashmun RA, Harris LC, Houghton PJ, Potter PM, Danks MK. Wagner LM, et al. Among authors: morton cl. Cancer Res. 2002 Sep 1;62(17):5001-7. Cancer Res. 2002. PMID: 12208753

5

Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice.

Morton CL, Iacono L, Hyatt JL, Taylor KR, Cheshire PJ, Houghton PJ, Danks MK, Stewart CF, Potter PM. Morton CL, et al. Cancer Chemother Pharmacol. 2005 Dec;56(6):629-36. doi: 10.1007/s00280-005-1027-y. Epub 2005 May 26. Cancer Chemother Pharmacol. 2005. PMID: 15918039

6

Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling.

Thimmaiah KN, Easton JB, Germain GS, Morton CL, Kamath S, Buolamwini JK, Houghton PJ. Thimmaiah KN, et al. J Biol Chem. 2005 Sep 9;280(36):31924-35. doi: 10.1074/jbc.M507057200. Epub 2005 Jul 11. J Biol Chem. 2005. PMID: 16009706 Free article.

7

The pediatric preclinical testing program: description of models and early testing results.

Houghton PJ, Morton CL, Tucker C, Payne D, Favours E, Cole C, Gorlick R, Kolb EA, Zhang W, Lock R, Carol H, Tajbakhsh M, Reynolds CP, Maris JM, Courtright J, Keir ST, Friedman HS, Stopford C, Zeidner J, Wu J, Liu T, Billups CA, Khan J, Ansher S, Zhang J, Smith MA. Houghton PJ, et al. Among authors: morton cl. Pediatr Blood Cancer. 2007 Dec;49(7):928-40. doi: 10.1002/pbc.21078. Pediatr Blood Cancer. 2007. PMID: 17066459

8

SK-NEP-1 and Rh1 are Ewing family tumor lines.

Smith MA, Morton CL, Phelps D, Girtman K, Neale G, Houghton PJ. Smith MA, et al. Pediatr Blood Cancer. 2008 Mar;50(3):703-6. doi: 10.1002/pbc.21099. Pediatr Blood Cancer. 2008. PMID: 17154184

9

Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis.

Whiteford CC, Bilke S, Greer BT, Chen Q, Braunschweig TA, Cenacchi N, Wei JS, Smith MA, Houghton P, Morton C, Reynolds CP, Lock R, Gorlick R, Khanna C, Thiele CJ, Takikita M, Catchpoole D, Hewitt SM, Khan J. Whiteford CC, et al. Among authors: morton c. Cancer Res. 2007 Jan 1;67(1):32-40. doi: 10.1158/0008-5472.CAN-06-0610. Cancer Res. 2007. PMID: 17210681

10

Evaluation of ABT-751 against childhood cancer models in vivo.

Morton CL, Favours EG, Mercer KS, Boltz CR, Crumpton JC, Tucker C, Billups CA, Houghton PJ. Morton CL, et al. Invest New Drugs. 2007 Aug;25(4):285-95. doi: 10.1007/s10637-007-9042-y. Epub 2007 Mar 24. Invest New Drugs. 2007. PMID: 17384918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,339 results

Search Page

Filters